Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells

被引:20
|
作者
Li, Deguan [1 ,2 ]
Chen, Renxiang [3 ]
Wang, Yi-Wen [3 ]
Fornace, Albert J., Jr. [3 ,4 ]
Li, Heng-Hong [3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China
[2] Peking Union Med Coll, Tianjin, Peoples R China
[3] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA
[4] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
基金
中国国家自然科学基金;
关键词
Programmed cell death protein 1 (PD-1); ionizing radiation; T cells; checkpoint blockade; ANTITUMOR IMMUNITY; UP-REGULATION; RADIATION; CANCER; MICROENVIRONMENT; ACTIVATION; RESISTANCE; RESPONSES; EXPOSURE; OVERCOME;
D O I
10.1080/09553002.2017.1400192
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: In this study we addressed the question whether radiation-induced adverse effects on T cell activation are associated with alterations of T cell checkpoint receptors. Materials and methods: Expression levels of checkpoint receptors on T cell subpopulations were analyzed at multiple post-radiation time points ranging from one to four weeks in mice receiving a single fraction of 1 or 4 Gy of c-ray. T cell activation associated metabolic changes were assessed. Results: Our results showed that prior irradiation resulted in significant elevated expression of programmed cell death protein 1 (PD-1) in both CD4+ and CD8+ populations, at all three post-radiation time points. T cells with elevated PD-1 mostly were either central memory or naive cells. In addition, the feedback induction of PD-1 expression in activated T cells declined after radiation. Conclusion: Taken together, the elevated PD-1 level observed at weeks after radiation exposure is connected to T cell dysfunction. Recent preclinical and clinical studies have showed that a combination of radiotherapy and T cell checkpoint blockade immunotherapy including targeting the programmed death-ligand 1 (PD-L1)/PD-1 axis may potentiate the antitumor response. Understanding the dynamic changes in PD-1 levels in T cells after radiation should help in the development of a more effective therapeutic strategy.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 50 条
  • [1] Prior irradiation results in elevated programmed death 1 (PD-1) in T cells
    Chen, Renxiang
    Li, Deguan
    Fornace, Albert J.
    Li, Henghong
    CANCER RESEARCH, 2017, 77
  • [2] Programmed cell death protein 1 (PD-1) in infection
    Leth, Steffen
    Jensen-Fangel, Soren
    APMIS, 2020, 128 (02) : 177 - 187
  • [3] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [4] Dynamics of expression of Programmed cell death protein-1 (PD-1) on T cells after allogeneic hematopoietic stem cell transplantation
    Simonetta, F.
    Pradier, A.
    Bosshard, C.
    Masouridi-Levrat, S.
    Dantin, C.
    Koutsi, A.
    Tirefort, Y.
    Roosnek, E.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S75 - S77
  • [5] Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation
    Simonetta, Federico
    Pradier, Amandine
    Bosshard, Carine
    Masouridi-Levrat, Stavroula
    Dantin, Carole
    Koutsi, Aikaterini
    Tirefort, Yordanka
    Roosnek, Eddy
    Chalandon, Yves
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [6] Enhanced expression of Programmed cell death 1 (PD-1) protein in benign vascular anomalies
    Amaya, Clarissa N.
    Wians, Frank H., Jr.
    Bryan, Brad A.
    Torabi, Alireza
    PATHOLOGY, 2017, 49 (03) : 292 - 296
  • [7] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Matthew J. Hadfield
    Howard Safran
    Marco A. Purbhoo
    Joseph E. Grossman
    Jennifer S. Buell
    Benedito A. Carneiro
    Oncogene, 2024, 43 : 758 - 762
  • [8] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Hadfield, Matthew J.
    Safran, Howard
    Purbhoo, Marco A.
    Grossman, Joseph E.
    Buell, Jennifer S.
    Carneiro, Benedito A.
    ONCOGENE, 2024, 43 (10) : 758 - 762
  • [9] Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes
    Granados, Hector M.
    Draghi, Andrew, II
    Tsurutani, Naomi
    Wright, Kyle
    Fernandez, Marina L.
    Sylvester, Francisco A.
    Vella, Anthony T.
    PLOS ONE, 2017, 12 (09):
  • [10] Maternal Programmed Cell Death Protein 1 (PD-1) Levels are Increased in Women with Preeclampsia.
    Wang, Yuping
    Gu, Yang
    Morgan, John
    Cooper, Danielle
    Lockhard, Claude
    Lockhard, Claude
    McCathran, Charles
    Lewis, David
    REPRODUCTIVE SCIENCES, 2019, 26 : 277A - 277A